102 related articles for article (PubMed ID: 21621302)
1. [Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].
Bernal M; Romero FJ; Souza DL; Gómez-Bernal FJ; Gómez-Bernal GJ
Actas Urol Esp; 2011 Sep; 35(8):470-4. PubMed ID: 21621302
[TBL] [Abstract][Full Text] [Related]
2. [Lung cancer projections for Aragon (Spain)].
Bernal M; Souza DL; Gómez FJ; Gómez GJ
Semergen; 2013; 39(4):191-6. PubMed ID: 23726730
[TBL] [Abstract][Full Text] [Related]
3. Estimation of bladder cancer projections in Spain.
Bernal-Pérez M; Souza DL; Romero-Fernández FJ; Gómez-Bernal G; Gómez-Bernal FJ
Actas Urol Esp; 2013 May; 37(5):286-91. PubMed ID: 23260185
[TBL] [Abstract][Full Text] [Related]
4. [Incidence, prevalence and mortality of kidney cancer in Spain: estimates and projections for the 1998-2022 period].
Souza DL; Bernal MM
Actas Urol Esp; 2012 Oct; 36(9):521-6. PubMed ID: 22196967
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiologic indicators of adenocarcinoma of the prostate. Results on 436 patients].
Arrizabalaga Moreno M; García González JI; Diez Rodríguez JM; Esteban Artiaga R; Castro Pita M; Navarro Sebastian J; Mora Durbán M; Paniagua Andrés P
Actas Urol Esp; 1997 Oct; 21(9):852-61. PubMed ID: 9471868
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer in American Indians, New Mexico, 1969 to 1994.
Gilliland FD; Key CR
J Urol; 1998 Mar; 159(3):893-7; discussion 897-8. PubMed ID: 9474177
[TBL] [Abstract][Full Text] [Related]
7. Predictions and estimations of colorectal cancer mortality, prevalence and incidence in Aragon, Spain, for the period 1998-2022.
Bezerra-de-Souza DL; Bernal MM; Gómez FJ; Gómez GJ
Rev Esp Enferm Dig; 2012; 104(10):518-23. PubMed ID: 23268630
[TBL] [Abstract][Full Text] [Related]
8. The rising incidence and mortality of prostate cancer in Belgrade population.
Janković J; Sipetić S
Coll Antropol; 2011 Jun; 35(2):499-503. PubMed ID: 21755724
[TBL] [Abstract][Full Text] [Related]
9. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer in Denmark. Incidence, morbidity and mortality.
Brasso K; Iverson P
Scand J Urol Nephrol Suppl; 1999; 203():29-33. PubMed ID: 10636567
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer mortality in Spain: estimating the future burden to the year 2028.
Cayuela A; Rodríguez-Dominguez S; López-Campos JL; Jara-Palomares L; Otero R; Vigil E
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1117-21. PubMed ID: 21740678
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological trends in prostate cancer over the last years].
Luján Galán M; Páez Borda A; Chiva Robles V; Santonja Garriga C; Romero Cajigal I; Berenguer Sánchez A
Arch Esp Urol; 2004 Oct; 57(8):817-25. PubMed ID: 15560270
[TBL] [Abstract][Full Text] [Related]
13. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening.
Merrill RM; Stephenson RA
J Urol; 2000 Feb; 163(2):503-10. PubMed ID: 10647666
[TBL] [Abstract][Full Text] [Related]
14. Projections of cancer mortality risks using spatio-temporal P-spline models.
Ugarte MD; Goicoa T; Etxeberria J; Militino AF
Stat Methods Med Res; 2012 Oct; 21(5):545-60. PubMed ID: 22547690
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of prostate cancer in the Limousin area].
Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
[TBL] [Abstract][Full Text] [Related]
16. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
[TBL] [Abstract][Full Text] [Related]
17. Quebec prostate cancer mortality dropped in 1996.
Meyer F; Moore L; Bairati I; Fradet Y
Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
[TBL] [Abstract][Full Text] [Related]
18. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
[TBL] [Abstract][Full Text] [Related]
19. The significance of changing trends in prostate cancer incidence and mortality.
Krongrad A; Lai S; Vidal EM
Semin Urol Oncol; 1998 Feb; 16(1):30-4. PubMed ID: 9508080
[TBL] [Abstract][Full Text] [Related]
20. High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
Hernes E; Johansson LA; Fosså SD; Pedersen AG; Glattre E
Eur J Cancer Prev; 2008 Aug; 17(4):331-5. PubMed ID: 18562957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
